08 - Rohrbasser - Electrophorese capillaire_projet PHARMELP
Transcription
08 - Rohrbasser - Electrophorese capillaire_projet PHARMELP
Capillary Electrophoresis project HES – Fribourg / Geneva University 14ème journée scientifique du CCCTA Les Diablerets 16 – 09 2010 Counterfeits medecines : situation The proportion of counterfeit medicines is dramatically increasing these days, in particular in some African countries pharmaceutical wholesalers where it was reported up to 80% of counterfeiting. Counterfeit Medecines A counterfeit medicine is a medicine that is deliberately and fraudulently mislabeled with respect to identity and/or source. Both branded and generic products can be concerned by the counterfeiting. Counterfeits may include products (i)with correct ingredients/components, (ii)with wrong ingredients/components, (iii)without active ingredients, (iv)with incorrect amounts of active ingredients or (v)with fake packaging. Drug quality control Project Context Countefeits drugs / Drug Quality control The methods actually used such as spectrophotometric based analysis (UV), Thin Layer Chromatography (TLC) or mainly liquid chromatography (LC) present numerous important drawbacks making them difficult to be used efficiently in the daily practice. Major problems are related to: the availability of reference substances, the maintenance of analytical instruments, the consumables availability and costs (analytical solvents of high quality grade) The most important issue of this project regards counterfeit medicines where Capillary Electrophoresis (CE) is perfectly adapted to rapidly evaluate the quality of the drugs and to give evidence for the presence of significant amounts of degradation impurities or absence of the active principle. Capillary Electrophoresis Acteurs principaux Convention 2006 Prof.C. C.Rohrbasser Rohrbasser Prof. Technologieindustrielle industrielle Technologie Ecoled’ingénieurs d’ingénieurset et Ecole d’architectesde deFribourg Fribourg d’architectes Section Sectiondes dessciences sciences Pharmaceutiques Pharmaceutiques Université Universitéde deGenève Genève Université de Université deLausanne Lausanne Dr DrS. S.Rudaz Rudaz Prof. J.-L. Prof. J.-L.Veuthey Veuthey Pharmaciede de Pharmacie l’HôpitalCantonal Cantonal l’Hôpital HUGGenève Genève HUG Prof.P. P.Bonnabry Bonnabry Prof. Prototype 1 2007 - 2008 Chef de projet et chimie analytique Claude Rohrbasser Systèmes intégrés Dominique Rhême Développement Raoul Buffat Samuel Roth Mattia Marangone Développement de méthodes, validation Jean-Luc Vauthey Serge Rudaz Energie Hubert Sauvain Chimie industrielle et appliquée, Olivier Vorlet, Olivier Naef Institut TI N 15 octobre 2008 Prototype ECB I + LED Detection Nouveauté mondiale Priorités Hauteur des Vials Pression De l’ordre de 4-5 mm max Système Vis ? Etanchéité ? (actuel sans) Système de rotation des carrousels Manipulation des vérins Changement De capillaire : Fragile Carrousels placés sur les côtés Ouverture de l’appareil sur l’arrière ECB 2 in « real » The data acquisition and processing software was also developed in house at HES-SO Fribourg by extending a program initially created for Gas and LC (Chromatos). Apparatus Comparison acidic conditions Methods development and validation DEVELOPMENT AND VALIDATION OF A METHOD FOR A NOVEL CAPILLARY ELECTROPHORESIS DEVICE FOR PHARMACEUTICAL ANALYSIS OF DRUGS BY MARÍA DE LOURDES AJA MONTES Birth of Pharmelp The Pharmelp association was born on September 22nd, 2009. LNS Bamako Mali 2009 Electrophorèse low cost The new devices ECB 4 & 5 Discussion Capillary electrophoresis (CE) is an attractive and complementary alternative to chromatographic techniques in different fields such as environmental, clinical, forensic, biochemical and more particularly pharmaceutical analysis and the Field of Counterfeits detection CE is now recognized by the regulatory authorities and can therefore be used in a validated analytical procedure according to ICH recommendations. Selectivity / Linearity / Precision – Trueness / Robustness, Accuracy Detection and quantification limits (LOD and LOQ) etc. 2010 Prototypes (2): 1.Cambodia : Dr. H. Ing / Prof. Bonnabry 2.Congo : Dr. R. Marini / Prof. PH. Hubert July 2010 We need your help Become member of the association Thank you